A systematic review and retrospective analysis of 1557 patients with advanced or metastatic solid cancers shows that high ALDH1 expression is distinctly associated with poorer overall survival (OS), especially in breast cancer, HNSCC, cervical cancer (CC), and ovarian cancers.21 This evidence concerns the gene ALDH1A1 and head and neck squamous cell carcinoma.